The esteemed Breakthrough Prizes 2025 are set to shine a spotlight on remarkable achievements in science, honoring trailblazers who have made significant contributions, especially in the realms of gene editing and public health.This year, three distinguished researchers from Harvard University—Alberto Ascherio, Joel Habener, and David Liu—have been recognized for their groundbreaking work that intertwines the complexities of the Epstein-Barr virus, GLP-1 treatments, and advancements in multiple sclerosis research.